Endotoxin and Cytokine Removal with a New (CA) Sorbent Cartridge
Blood Purification · 14.07.2025 · 55 (6-7) · 464-472
DOI: 10.1159/000547419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, online erschienen am 14.07.2025. Verfasst von Anna Lorenzin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy, lorenzin.anna@gmail.com. Hauptthemen laut MEDLINE: Lipopolysaccharides, Endotoxins, Cytokines, Interleukin-1beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Introduction
Endotoxin, also referred to as lipopolysaccharide (LPS), is a major stimulus of the inflammatory response capable of leading to sepsis and septic shock. Extracorporeal blood purification therapies are increasingly employed in the treatment of sepsis. Timely and thorough removal of endotoxin and cytokines can help mitigate the inflammatory cascade during septic shock. Hemoadsorption (HA) is a promising approach to achieve this goal. In this study, we analyzed different prototypes of a new CA cartridge: we performed in vitro circulations to define endotoxin and cytokine removal capacity.
Methods
In vitro HA was performed using GALILEO testing platform, and customized circuits with mini-modules of CA cartridge were prepared. A batch of 500 mL of blood preconditioned with LPS was utilized for each circulation. We collected samples at different time points: endotoxin activity and removal ratio (RR) of LPS, interleukin 6 (IL-6), and interleukin-1 beta (IL-1β) were assessed.
Results
The prototypes showed different performances, highlighting promising adsorption affinity toward the target molecules. A potentially clinically meaningful reduction of endotoxin activity by CA mini-module was observed. Concentration of the LPS, and cytokines IL-6 and IL-1β showed a significant reduction over time, as confirmed by the RRs.
Conclusion
Our experiments allowed to characterize the prototypes in terms of adsorption capacity for both endotoxin and cytokines. After this preliminary approach, the final CA mini-module was tested under the same experimental conditions and displayed excellent adsorption capacity, indicating its potential application for endotoxin removal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy, lorenzin.anna@gmail.com.
- International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy, lorenzin.anna@gmail.com.
- Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
- International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy.
Zitieren
APA
Lorenzin, A., Perin, N., de Cal, M., Zanella, M., & Ronco, C. (2025). Endotoxin and Cytokine Removal with a New (CA) Sorbent Cartridge. Blood Purification, 55(6-7), 464-472. https://doi.org/10.1159/000547419
Vancouver
Lorenzin A, Perin N, de Cal M, Zanella M, Ronco C. Endotoxin and Cytokine Removal with a New (CA) Sorbent Cartridge. Blood Purification. 2025;55(6-7):464-472. doi:10.1159/000547419
BibTeX
@article{Lorenzin2025,
author = {Lorenzin, Anna and Perin, Natascha and de Cal, Massimo and Zanella, Monica and Ronco, Claudio},
title = {Endotoxin and Cytokine Removal with a New (CA) Sorbent Cartridge},
journal = {Blood Purification},
year = {2025},
volume = {55},
number = {6-7},
pages = {464--472},
doi = {10.1159/000547419}
}
EUVIMED